Skip to search formSkip to main contentSkip to account menu

Eprosartan mesylate

Known as: (E)-2-Butyl-1-(p-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic Acid, Monomethanesulfonate, 2-Thiophenepropanoic Acid, alpha-((2-butyl-1-((4-carboxyphenyl)methyl)-1H-imidazol-5-yl)methylene)-,(E)-, Monomethanesulfonate 
The mesylate salt form of eprosartan, a non-biphenyl, non-tetrazole, nonpeptide angiotensin II antagonist with antihypertensive activity. Eprosartan… 
National Institutes of Health

Related topics

Related topics

12 relations
Angiotensin 2 Receptor Antagonists [MoA]Angiotensin 2 Type 1 Receptor Antagonists [MoA]Congestive heart failureDecreased Blood Pressure [PE]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
FORMULATION AND EVALUATION OF LIQUISOLID COMPACT OF EPROSARTAN MESYLATE
Liquisolid technique is a new approach for delivery of drugs through oral cavity. This technique is suitable for poorly or water… 
2015
2015
Development and Validation of RP-HPLC Method for Determination of Eprosartan Mesylate in Rat Plasma: Application to Preclinical Pharmacokinetic Study
A selective and sensitive reverse phase high performance liquid chromatography (RP-HPLC) method was developed and validated for… 
2014
2014
PREPARATION & EVALUATION OF EPROSARTAN MESYLATE SOLID DISPERSIONS
The aim of the present study was to improve the solubility and bioavailability of a poorly water-soluble drug in human body… 
2011
2011
Study of forced degradation behaviour of eprosartan mesylate and development of validated stability indicating assay method by UPLC
ISSN 0326-2383 
2009
2009
The estimation of eprosartan mesylate in pharmaceutical dosage forms by RP-HPLC
A simple, precise, rapid and accurate reverse phase HPLC method developed for the estimation of Eprosartan mesylate in tablet… 
2009
2009
Single dosage pharmaceutical formulation comprising eprosartan mesylate
It comprises eprosartan mesylate in particulate form, at least 65v / v% eprosartan mesylate particles fall from a particle size… 
2009
2009
Tablets containing eprosartan mesylate
It describes a tablet comprising eprosartan mesylate in either the only form of anhydrous or dihydrate form. In another… 
2008
2008
Novel saltforming process of eprosartan mesylate
The invention discloses a new salt formation technology for Eprosartan mesilate salt, namely, the Eprosartan is dissolved or… 
2002
2002
[Eprosartan mesylate in controlling of blood pressure in patients with ischemic stroke].
In 20 patients with ischemic stroke and moderate or severe arterial hypertension the effectiveness of eprosartan mesilat (Teveten… 
1999
1999
Eprosartan enthaltende wirksamere formulierungen in oraler fester darreichungsform